FDA Encourages Manufacturers To Call Out Social Media Misinformation

By Jessica Karins / July 8, 2024 at 5:58 PM
A new FDA guidance for medical product manufacturers on dealing with misinformation about their products encourages the companies to directly respond to instances of misinformation posted by influential sources online, including those promoting unapproved indications. Calling on the manufacturers of drugs or devices to take more action on misinformation may help FDA take on the problem, since it faces some limits in combating the problem itself despite a focus from high-level officials. Statements on unapproved uses of drugs, in particular,...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.